Zomedica Pharmaceuticals

OverviewSuggest Edit

Zomedica Pharmaceuticals is a veterinary pharmaceutical company targeting health and wellness solutions for companion animals (canine, feline and equine). Its portfolio of products includes veterinary-approved drugs combined with delivery systems, as well as devices, diagnostics and other solutions deemed appropriate for veterinary use.

TypePublic
Founded2015
HQAnn Arbor, MI, US
Websitezomedica.com

Latest Updates

Employees (est.) (Dec 2019)28(+4%)
Share Price (Sept 2021)$0.6(-1%)
Cybersecurity ratingAMore

Key People/Management at Zomedica Pharmaceuticals

Jeff Rowe

Jeff Rowe

Chairman
Robert Cohen

Robert Cohen

Chief Executive Officer, Executive Member
Bruk Herbst

Bruk Herbst

Chief Commercial Officer
Johnny D. Powers

Johnny D. Powers

Director
Stephanie Morley

Stephanie Morley

President and Chief Medical Officer
Ann Cotter

Ann Cotter

Chief Financial Officer
Show more

Zomedica Pharmaceuticals Office Locations

Zomedica Pharmaceuticals has an office in Ann Arbor
Ann Arbor, MI, US (HQ)
3928 Varsity Dr
Ann Arbor, MI, US
3928 Varsity Dr
Show all (2)

Zomedica Pharmaceuticals Financials and Metrics

Zomedica Pharmaceuticals Revenue

USD

Revenue (Q1, 2021)

14.1k

Gross profit (Q1, 2021)

8.5k

Gross profit margin (Q1, 2021), %

59.9%

Net income (Q1, 2021)

(4.0m)

EBIT (Q1, 2021)

(3.9m)

Market capitalization (8-Sept-2021)

562.7m

Closing stock price (8-Sept-2021)

0.6

Cash (31-Mar-2021)

276.6m

EV

287.2m
Zomedica Pharmaceuticals's current market capitalization is $562.7 m.
Annual
USDFY, 2016FY, 2017FY, 2018

General and administrative expense

2.9m3.9m4.5m

R&D expense

1.5m2.8m10.3m

Operating expense total

4.4m6.7m14.8m

Depreciation and amortization

45.8k92.4k205.8k
Quarterly
USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

14.1k

Cost of goods sold

5.7k

Gross profit

8.5k

Gross profit Margin, %

60%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

3.2m3.4m1.9m510.6k62.0m

Accounts Receivable

18.9k28.3k53.7k67.6k146.2k

Prepaid Expenses

332.6k786.3k

Current Assets

3.6m4.3m3.9m1.8m62.9m
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Cash

4.3m526.8k2.3m5.8m2.5m1.5m29.1m276.6m

Accounts Receivable

49.6k37.7k78.0k95.6k76.0k142.5k182.5k8.5k

Prepaid Expenses

84.7k67.3k70.5k103.0k74.1k159.1k

Inventories

309.7k
Annual
USDFY, 2017FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(5.7m)(8.1m)(16.6m)(19.8m)(16.9m)

Depreciation and Amortization

45.8k92.4k205.8k1.1k181.7k

Accounts Payable

552.6k94.3k1.5m(289.0k)(838.9k)

Cash From Operating Activities

(4.6m)(7.1m)(11.1m)(15.6m)(16.2m)
Quarterly
USDQ2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Net Income

(6.3m)(8.2m)(11.7m)(14.1m)(16.9m)(2.5m)(7.8m)(4.0m)

Depreciation and Amortization

64.2k150.3k62.1k131.0k201.1k76.4k154.3k59.3k

Inventories

(309.7k)

Accounts Payable

855.1k451.6k5.4m(579.7k)(799.0k)(508.6k)(883.4k)(120.4k)
USDFY, 2016

Financial Leverage

1.2 x
Show all financial metrics

Zomedica Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Zomedica Pharmaceuticals Online and Social Media Presence

Embed Graph

Zomedica Pharmaceuticals News and Updates

Thinking about buying stock in Zomedica Pharmaceuticals, Boxlight Corp, Vaxart Inc, Delta Air Lines, or BP?

NEW YORK, Sept. 25, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, BOXL, VXRT, DAL, and BP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Zomedica Pharmaceuticals, iBio Inc, Achieve Life Sciences, Intec Pharma, or Apple Inc?

NEW YORK, July 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, IBIO, ACHV, NTEC, and AAPL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Seanergy Maritime, Tesla, Royal Caribbean Cruises, Zomedica Pharmaceuticals, or Hertz?

NEW YORK, July 9, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SHIP, TSLA, RCL, ZOM, and HTZ. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Novavax, TOP Ships, Zomedica Pharmaceuticals, Waitr Holdings, or Endo International?

NEW YORK, July 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVAX, TOPS, ZOM, WTRH, and ENDP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Sorrento Therapeutics, Zomedica Pharmaceuticals, TOP Ships, Nokia, or Microsoft Corp?

NEW YORK, July 2, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SRNE, ZOM, TOPS, NOK, and MSFT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering

ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing of its previously announced public offering of 187,500,000 common shares (or common share equivalents…
Show more

Zomedica Pharmaceuticals Blogs

Cultivating Partnerships to Enhance Communities

It’s no secret that science and medicine are very competitive industries. Veterinary schools have an acceptance rate of 10-20%, and it seems to get lower each year. If you aren’t aware of how you compare to other students, don’t worry! Many veterinary schools statistics so you can see how you compar…

Applying Your Past and Building Your Future

When applying to vet school, you’re asked repeatedly why you want to be a veterinarian. You fill out essays, surveys, and timelines. You attend interviews and meet with existing students. All to help the school understand why you are suited to be a veterinarian. When I applied to veterinary school, …

Protecting Your Time and Building Your Value

There’s a famous line every first-year vet student hears at my school during orientation week. After meeting your new classmates and going over curriculum expectations, we gather in a large lecture hall for our professor to give us the legendary speech that nearly every student in the last couple de…

Learning Best Practices and Developing Your Own

In a couple months, I will be starting the third year of my DVM program. After one more year of didactic coursework, I will be entering clinics and practicing medicine with real, living, breathing patients. In preparation for this exciting and nerve-wracking time, I have sought advice from veterinar…

COVID-19 Internship: Impact of COVID-19 in Veterinary Medicine

It’s difficult to grasp the idea that not too long ago, the word “coronavirus” probably didn’t evoke strong emotions for most individuals. It’s now difficult to find a person who hasn’t been deeply affected by the word. I have struggled with how to develop the right tone for this article, as I want …

Meet Anna Blick, Future DVM!

The blog is back! As many of you may have noticed, our Zomedica blog has been dark since December 2019. Zomedica is a very lean and young organization; admittedly, we are coming out of a phase of “blog burnout”. We were struggling with our voice, what to say, how to say it, and whom on the team had …
Show more

Zomedica Pharmaceuticals Frequently Asked Questions

  • When was Zomedica Pharmaceuticals founded?

    Zomedica Pharmaceuticals was founded in 2015.

  • Who are Zomedica Pharmaceuticals key executives?

    Zomedica Pharmaceuticals's key executives are Jeff Rowe, Robert Cohen and Bruk Herbst.

  • How many employees does Zomedica Pharmaceuticals have?

    Zomedica Pharmaceuticals has 28 employees.

  • Who are Zomedica Pharmaceuticals competitors?

    Competitors of Zomedica Pharmaceuticals include Patterson Veterinary Supply, Avacta Group and Lintjeshof.

  • Where is Zomedica Pharmaceuticals headquarters?

    Zomedica Pharmaceuticals headquarters is located at 3928 Varsity Dr, Ann Arbor.

  • Where are Zomedica Pharmaceuticals offices?

    Zomedica Pharmaceuticals has an office in Ann Arbor.

  • How many offices does Zomedica Pharmaceuticals have?

    Zomedica Pharmaceuticals has 2 offices.